Target intelligence / Profile preview

Naïve B-cell receptor specific for pneumococcal capsular polysaccharide epitopes (PPS-specific BCR)

Target
PPS-specific BCR
Molecular classification
Receptor, Immunoglobulin family, Membrane-bound immunoglobulin
01

Overview

Naïve B-cell receptors specific for pneumococcal capsular polysaccharide (PPS) epitopes are membrane-bound immunoglobulins expressed on the surface of B lymphocytes that have not yet encountered their specific antigen. These receptors are the primary sensors for the complex carbohydrate capsules of Streptococcus pneumoniae, which are critical for bacterial virulence and immune evasion (Clutterbuck et al., 2012, PubMed: 22302121). Upon binding to PPS epitopes, these receptors initiate intracellular signaling cascades that drive B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells (Janeway et al., 2001, Immunobiology). In clinical practice, these receptors are the targets of pneumococcal vaccines; pure polysaccharide vaccines (e.g., PPSV23) act by cross-linking these receptors to induce a T-cell independent response, while conjugate vaccines (e.g., PCV13, PCV20) utilize protein carriers to engage T-cell help (Pollard et al., 2009, Nature Reviews Immunology). The effectiveness of these vaccines depends on the ability of the naïve BCR repertoire to recognize diverse serotypes and transition into high-affinity memory B cells. Understanding the interaction between these receptors and various polysaccharide structures is vital for addressing challenges such as serotype replacement and age-related immunosenescence (CDC, 2023).

Other names
Pneumococcal polysaccharide-specific B-cell receptorAnti-PPS BCRPPS-specific naïve B-cell receptorPneumococcal capsular polysaccharide-binding B-cell receptor
02

Mechanism of action

Antigen-mediated cross-linking of B-cell receptors on naïve B cells, which triggers the Ig-alpha/Ig-beta signaling complex, leading to B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells.

03

Biological functions

Immune responseAntigen recognitionB-cell activationAntibody productionSignal transduction
04

Disease associations

InfectionPneumoniaMeningitisSepsisBacteremia
05

Safety considerations

Immunological hyporesponsiveness (tolerance) with repeated polysaccharide dosesLimited efficacy in infants and children under 2 years for non-conjugated polysaccharidesSerotype replacement in the populationPotential for reduced response in immunocompromised individuals
06

Interacting drugs

Pneumococcal polysaccharide vaccine (PPSV23)

6 more in the full profile.

07

Biomarkers

Anti-pneumococcal capsular polysaccharide IgG titersAnti-pneumococcal capsular polysaccharide IgM titersOpsonophagocytic activity (OPA) titersPPS-specific B-cell frequency (ELISpot)

Beyond the preview

Go deeper on Naïve B-cell receptor specific for pneumococcal capsular polysaccharide epitopes (PPS-specific BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naïve B-cell receptor specific for pneumococcal capsular polysaccharide epitopes (PPS-specific BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call